FATE Fate Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ 10-K/10-Q Aug 13, 2026
$2.11
· of 52w range
· above low
· to high
$0.9552w low
$3.2352w high
Market Cap (MRQ)
$246M
P/E (TTM)
-2.0
EPS (TTM)
$-1.05
Revenue (TTM)
$6M
your badges
52W Range
$1–$3
Analyst Rating
HOLD
Price Target
$6
P/E
-2.0
ROE
-60.7%
Net Profit Margin
-1941.1%
Your badge strip is empty — pin a metric anywhere on this page.
FATE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.11
Market Cap (MRQ)
$246M
P/E (TTM)
-2.0
EPS (TTM)
$-1.05
Revenue (TTM)
$6M
ROE (TTM)
-60.7%
52W Range
$1–$3
FATE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Fate Therapeutics, Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees161
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$7M2016-12-31 → 2025-12-31
EPS$-1.152020-12-31 → 2025-12-31
Free Cash Flow$-112M2016-12-31 → 2025-12-31
Net margin-1941.1%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | FATE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -2.05Y avg ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 37.95Y avg ≈29.4 | ≈29.4 | 48.5 | Fair value | |
| P/B (MRQ) | 1.65Y avg ≈2.5 | ≈2.5 | 2.5 | Undervalued | |
| Price / FCF (TTM) | -2.35Y avg ≈-7.0 | ≈-7.0 | · | · | |
| Price / Cash Flow (TTM) | -2.45Y avg ≈-8.7 | ≈-8.7 | · | · | |
| Price / Tangible Book | 1.25Y avg ≈2.5 | ≈2.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | FATE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -2058.1%5Y avg ≈-954.7% | ≈-954.7% | -126.3% | Weak | |
| EBITDA Margin (TTM) | -1873.4%5Y avg ≈-877.4% | ≈-877.4% | -126.3% | Weak | |
| Net Profit Margin (TTM) | -1941.1%5Y avg ≈-868.7% | ≈-868.7% | -177.4% | Weak | |
| ROA (TTM) | -39.9%5Y avg ≈-32.8% | ≈-32.8% | -38.5% | In line | |
| ROE (TTM) | -60.7%5Y avg ≈-48.2% | ≈-48.2% | -51.9% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | FATE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.85Y avg ≈6.8 | ≈6.8 | 6.4 | Low liquidity | |
| Quick Ratio (MRQ) | 4.75Y avg ≈5.4 | ≈5.4 | 5.5 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | FATE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -51.2%5Y avg ≈-2.7% | ≈-2.7% | · | · | |
| Revenue CAGR 3Y | -59.0%5Y avg ≈-23.4% | ≈-23.4% | · | · | |
| Revenue CAGR 5Y | -26.7% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | FATE | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.1 | ≈0.1 | 0.0 | Below avg | |
| Receivables Turnover | 3.05Y avg ≈4.6 | ≈4.6 | 2.4 | Top tier | |
| Revenue / Employee | ≈$41.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
10.6%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.25 | $-0.27 | 8.5% |
| March 31, 2026 | May 11, 2026 | $-0.26 | $-0.29 | 9.0% |
| Dec. 31, 2025 | $-0.27 | $-0.28 | 1.9% | |
| Sept. 30, 2025 | $-0.27 | $-0.30 | 9.1% | |
| June 30, 2025 | $-0.29 | $-0.35 | 17.0% | |
| March 31, 2025 | $-0.32 | $-0.39 | 18.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | · | |
| R&D Expense | $108M | $135M | $173M | $320M | $216M | $126M | $88M | $56M | $34M | $26M | $20M | $16M | |
| SG&A Expense | $47M | $74M | $81M | $84M | $57M | $34M | $24M | $16M | $12M | $10M | $10M | $8M | |
| Operating Expenses | $154M | $224M | $254M | $405M | $273M | $160M | $111M | $72M | $46M | $36M | $30M | $25M | |
| Operating Income | $-148M | $-210M | $-191M | $-308M | $-217M | $-128M | $-101M | $-67M | $-42M | $-32M | $-28M | $-25M | |
| Interest Expense | · | · | · | · | $0 | $0 | $2M | $2M | $1M | $2M | $2M | $549.0K | |
| Interest Income | $11M | $17M | $17M | $6M | $1M | $2M | $4M | $2M | $559.0K | $138.0K | $10.0K | $2.0K | |
| Other Non-op | $11M | $24M | $30M | $27M | $5M | $-45M | $3M | $494.0K | $-827.0K | $-1M | $-2M | $-979.0K | |
| Income Tax | $2.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| EPS (Basic) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| Shares (Basic) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| Shares (Diluted) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| EBITDA | $-135M | $-191M | $-172M | $-295M | $-211M | $-125M | $-99M | $-66M | $-41M | $-31M | $-27M | $-24M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $42M | $61M | $134M | $167M | $100M | $191M | $89M | $89M | $65M | $49M | |
| Short-term Investments | $157M | $243M | $273M | $375M | $482M | · | · | · | · | $4M | · | · | |
| Receivables | $916.0K | $4M | $2M | $38M | $9M | $6M | · | $500.0K | · | · | · | · | |
| Prepaid Expense | $4M | $9M | $15M | $27M | $9M | $6M | $6M | $4M | $2M | $1M | $843.0K | $760.0K | |
| Current Assets | $209M | $292M | $332M | $502M | $633M | $494M | $227M | $205M | $103M | $93M | $66M | $50M | |
| PP&E (Net) | $57M | $64M | $97M | $110M | $92M | $32M | $11M | $5M | $3M | $2M | $2M | $1M | |
| PP&E (Gross) | $93M | $100M | $144M | $140M | $108M | $43M | $20M | $11M | $8M | $6M | $6M | $4M | |
| Accum. Depreciation | $36M | $35M | $48M | $30M | $17M | $11M | $9M | $6M | $5M | $4M | $3M | $3M | |
| Other Non-current Assets | $0 | $9.0K | $9.0K | $33.0K | $33.0K | $9.0K | $9.0K | $526.0K | $24.0K | $24.0K | $24.0K | $10.0K | |
| Total Assets | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Accounts Payable | $3M | $9M | $5M | $8M | $9M | $6M | $6M | $4M | $2M | $934.0K | $996.0K | $645.0K | |
| Accrued Liabilities | $20M | $21M | $28M | $54M | $42M | $16M | $15M | $11M | $7M | $4M | $2M | $2M | |
| Current Liabilities | $36M | $39M | $39M | $114M | $81M | $86M | $28M | $27M | $11M | $15M | $13M | $5M | |
| Capital Leases | $73M | $78M | $97M | $104M | $109M | $94M | $25M | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $18M | $19M | $13M | $22M | $20M | |
| Total Debt | · | · | · | · | · | · | · | $15M | $15M | $11M | $18M | $20M | |
| Common Stock | $115.0K | $114.0K | $99.0K | $97.0K | $96.0K | $88.0K | $76.0K | $65.0K | $53.0K | $41.0K | $29.0K | $21.0K | |
| Paid-in Capital | $1.74B | $1.72B | $1.58B | $1.54B | $1.45B | $941M | $628M | $446M | $296M | $249M | · | $141M | |
| Retained Earnings | $-1.53B | $-1.40B | $-1.21B | $-1.05B | $-769M | $-557M | $-384M | $-285M | $-219M | $-176M | $-142M | $-112M | |
| AOCI | $116.0K | $268.0K | $15.0K | $-2M | $-762.0K | $70.0K | $22.0K | $-2.0K | $-3.0K | $-1.0K | · | · | |
| Stockholders' Equity | $207M | $319M | $368M | $484M | $679M | $384M | $245M | $160M | $77M | $73M | $38M | $28M | |
| Liabilities + Equity | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Shares Outstanding | 115,359,735 | 113,928,279 | 98,627,076 | 97,294,917 | 95,726,962 | 87,722,237 | 75,730,260 | 64,693,681 | 52,648,601 | 41,386,506 | 28,716,570 | 20,569,399 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $19M | $18M | $14M | $6M | $3M | $2M | $1M | $971.0K | $881.0K | $687.0K | $496.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Restructuring | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $17M | $44M | $10M | $20M | $43M | $131M | $13M | $27M | $5M | $3M | $9M | $534.0K | |
| Operating Cash Flow | $-106M | $-123M | $-132M | $-248M | $-163M | $-39M | $-83M | $-39M | $-37M | $-30M | $-18M | $-22M | |
| CapEx | $6M | $730.0K | $6M | $36M | $51M | $5M | $7M | $2M | $2M | $457.0K | $1M | $882.0K | |
| Investing Cash Flow | $111M | $12M | $113M | $167M | $-324M | $-161M | $-157M | $-463.0K | $-10M | $-4M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $15M | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $-15M | · | $4M | $-8M | $-2M | $18M | |
| Stock Issued | · | · | · | · | $412M | $189M | $162M | $135M | $43M | · | $5M | $142.0K | |
| Net Stock Activity | · | · | · | · | $412M | $189M | $162M | · | · | · | $5M | $142.0K | |
| Financing Cash Flow | $5M | $100M | $85.0K | $9M | $453M | $283M | $150M | $141M | $47M | $58M | · | · | |
| Net Change in Cash | $11M | $-11M | $-20M | $-72M | $-34M | $83M | $-91M | $102M | $343.0K | $24M | $16M | $-5M | |
| Taxes Paid | $1.6K | $1.7K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-112M | $-124M | $-138M | $-284M | $-214M | $-44M | $-91M | $-41M | $-39M | $-30M | $-20M | $-23M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% | -943.1% | -1415.4% | · | · | -1142.8% | · | |
| Net Margin | -2051.1% | -1366.5% | -253.3% | -292.6% | -379.9% | -551.6% | -919.0% | -1405.0% | · | · | -1233.7% | · | |
| EBITDA Margin | -2028.3% | -1403.5% | -271.1% | -305.9% | -378.1% | -397.7% | -922.6% | -1390.0% | · | · | -1114.6% | · | |
| ROA | -35.9% | -39.3% | -26.6% | -34.6% | -27.5% | -37.5% | -38.1% | -41.8% | -42.9% | -41.1% | -50.3% | -48.5% | |
| ROE | -58.2% | -54.7% | -41.7% | -56.2% | -30.1% | -42.9% | -38.3% | -39.8% | -69.9% | -60.2% | -90.4% | -65.4% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 | 5.8 | 8.2 | 7.5 | 9.3 | 6.1 | 4.9 | 10.9 | |
| Quick Ratio | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 | 2.0 | 3.6 | 7.0 | 8.1 | 6.1 | 4.8 | 10.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.1 | 0.5 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.0 | 0.3 | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | -57.5 | -39.6 | -33.2 | -19.5 | -12.5 | -45.4 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | 0.0 | · | |
| Receivables Turnover | 3.0 | 5.1 | 3.2 | 4.1 | 7.9 | 10.5 | · | 19.0 | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.80 | $2.80 | $3.74 | $4.97 | $7.09 | $4.38 | $3.23 | $2.48 | $1.47 | $1.77 | $1.32 | $1.38 | |
| Revenue / Share | $0.06 | $0.12 | $0.65 | $0.99 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.89 | $-1.08 | $-1.34 | $-2.56 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.32 | $0.42 | $0.63 | $1.40 | $1.91 | $1.32 | $2.94 | $1.69 | $2.14 | $2.26 | $2.39 | |
| EPS (TTM) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -51.2% | -78.5% | -34.0% | 72.4% | 77.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.0% | -37.5% | 26.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.7% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | $2M | |
| Net Income TTM | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| Market Cap | $113M | $188M | $369M | $982M | $5.60B | $7.98B | $1.48B | $830M | $322M | $104M | $97M | $103M | |
| Enterprise Value | · | · | · | · | · | · | · | $654M | $248M | $22M | $50M | $74M | |
| P/E | -0.9 | -1.0 | -2.3 | -3.5 | -26.1 | -43.3 | · | · | · | · | · | · | |
| P/S | 17.0 | 13.8 | 5.8 | 10.2 | 100.3 | 253.8 | 138.8 | 175.1 | 78.3 | 23.6 | 39.8 | 64.1 | |
| P/B | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | 6.1 | 5.2 | 4.2 | 1.4 | 2.5 | 3.7 | |
| P / Tangible Book | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.1 | -1.5 | -2.8 | -4.0 | -34.4 | -203.3 | -17.8 | -21.5 | -8.7 | -3.5 | -5.3 | -4.6 | |
| P / FCF | -1.0 | -1.5 | -2.7 | -3.5 | -26.2 | -180.6 | -16.4 | -20.3 | -8.3 | -3.4 | -4.9 | -4.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | -9.9 | -6.0 | -0.7 | -1.9 | -3.0 | |
| EV / FCF | · | · | · | · | · | · | · | -16.0 | -6.4 | -0.7 | -2.5 | -3.2 | |
| EV / Revenue | · | · | · | · | · | · | · | 138.1 | 60.3 | 5.1 | 20.7 | 45.8 | |
| Earnings Yield | -117.3% | -99.4% | -43.9% | -28.8% | -3.8% | -2.3% | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $7M | $2M | $2M | $2M | $933.0K | $59M | $44M | $15M | |
| R&D Expense | $24M | $25M | $25M | $26M | $27M | $29M | $34M | $35M | $35M | $32M | $32M | $34M | $41M | $66M | $87M | $80M | |
| SG&A Expense | $9M | $10M | $11M | $11M | $11M | $14M | $15M | $21M | $17M | $21M | $18M | $19M | $23M | $22M | $22M | $22M | |
| Operating Expenses | $33M | $34M | $36M | $36M | $39M | $43M | $64M | $55M | $52M | $53M | $50M | $53M | $63M | $88M | $109M | $101M | |
| Operating Income | $-31M | $-33M | $-35M | $-35M | $-37M | $-41M | $-62M | $-52M | $-45M | $-51M | $-48M | $-51M | $-63M | $-29M | $-64M | $-86M | |
| Interest Income | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $4M | $4M | $5M | $4M | $4M | $3M | $2M | |
| Other Non-op | $975.0K | $2M | $2M | $2M | $3M | $4M | $10M | $5M | $7M | $3M | $4M | $6M | $10M | $10M | $8M | $3M | |
| Net Income | $-30M | $-31M | $-32M | $-32M | $-34M | $-38M | $-52M | $-48M | $-38M | $-48M | $-44M | $-45M | $-53M | $-19M | $-56M | $-84M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| Shares (Basic) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| Shares (Diluted) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| EBITDA | $-31M | $-30M | · | $-35M | $-37M | $-38M | · | $-52M | $-45M | $-46M | · | $-51M | $-63M | $-24M | · | $-86M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $40M | $47M | $41M | $41M | $45M | $36M | $38M | $37M | $121M | $42M | $33M | $47M | $42M | $61M | $82M | |
| Short-term Investments | $121M | $135M | $157M | $175M | $182M | $196M | $243M | $259M | $268M | · | $273M | · | · | · | $375M | · | |
| Receivables | $703.0K | $704.0K | $916.0K | $682.0K | $1M | $2M | $4M | $4M | $1M | $858.0K | $2M | $2M | $3M | $14M | $38M | $10M | |
| Prepaid Expense | $3M | $4M | $4M | $5M | $6M | $5M | $9M | $9M | $13M | $10M | $15M | $13M | $11M | $15M | $27M | $20M | |
| Current Assets | $158M | $180M | $209M | $221M | $230M | $248M | $292M | $310M | $319M | $394M | $332M | $364M | $392M | $438M | $502M | $535M | |
| PP&E (Net) | $52M | $54M | $57M | $59M | $61M | $63M | $64M | $82M | $88M | $92M | $97M | $102M | $106M | $109M | $110M | $109M | |
| PP&E (Gross) | · | · | $93M | · | · | · | $100M | · | · | · | $144M | · | · | · | $140M | · | |
| Accum. Depreciation | · | · | $36M | · | · | · | $35M | · | · | · | $48M | · | · | · | $30M | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $0 | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $33.0K | $33.0K | $33.0K | $33.0K | |
| Total Assets | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Accounts Payable | $3M | $3M | $3M | $4M | $4M | $4M | $9M | $6M | $5M | $7M | $5M | $6M | $8M | $10M | $8M | $10M | |
| Accrued Liabilities | $15M | $14M | $20M | $18M | $18M | $17M | $21M | $24M | $23M | $32M | $28M | $29M | $29M | $32M | $54M | $50M | |
| Current Liabilities | $33M | $31M | $36M | $28M | $29M | $28M | $39M | $37M | $35M | $45M | $39M | $41M | $45M | $49M | $114M | $104M | |
| Capital Leases | $71M | $72M | $73M | $74M | $76M | $77M | $78M | $92M | $94M | $96M | $97M | $99M | $101M | $102M | $104M | $105M | |
| Common Stock | $117.0K | $116.0K | $115.0K | $115.0K | $115.0K | $115.0K | $114.0K | $114.0K | $114.0K | $114.0K | $99.0K | $99.0K | $99.0K | $98.0K | $97.0K | $97.0K | |
| Paid-in Capital | $1.75B | $1.75B | $1.74B | $1.74B | $1.73B | $1.72B | $1.72B | $1.71B | $1.70B | $1.69B | $1.58B | $1.57B | $1.56B | $1.55B | $1.54B | $1.52B | |
| Retained Earnings | $-1.60B | $-1.57B | $-1.53B | $-1.50B | $-1.47B | $-1.44B | $-1.40B | $-1.35B | $-1.30B | $-1.26B | $-1.21B | $-1.17B | $-1.12B | $-1.07B | $-1.05B | $-994M | |
| AOCI | $-117.0K | $-77.0K | $116.0K | $153.0K | $62.0K | $191.0K | $268.0K | $835.0K | $-422.0K | $-194.0K | $15.0K | $-499.0K | $-587.0K | $-646.0K | $-2M | $-3M | |
| Stockholders' Equity | $153M | $180M | $207M | $234M | $261M | $288M | $319M | $362M | $397M | $426M | $368M | $403M | $438M | $477M | $484M | $518M | |
| Liabilities + Equity | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Shares Outstanding | 116,694,106 | 116,272,513 | 115,359,735 | 115,336,697 | 114,655,067 | 114,603,910 | 113,928,279 | 113,884,884 | 113,849,557 | 113,798,942 | 98,627,076 | 98,585,750 | 98,522,718 | 98,191,015 | 97,294,917 | 97,112,209 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $3M | |
| Restructuring | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-3M | · | · | · | $479.0K | · | · | · | $10M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-23M | $-31M | $-23M | $-24M | $-25M | $-34M | $-28M | $-29M | $-32M | $-33M | $-37M | $-38M | $-28M | $-29M | $-75M | $-55M | |
| CapEx | $80.0K | $239.0K | $1M | $2M | $1M | $1M | $98.0K | $495.0K | $51.0K | $86.0K | $181.0K | $565.0K | $2M | $3M | $7M | $9M | |
| Investing Cash Flow | $15M | $24M | $28M | $21M | $20M | $43M | $23M | $25M | $-53M | $17M | $45M | $25M | $33M | $9M | $53M | $80M | |
| Stock Issued | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $2M | $2M | $1M | $0 | $3M | $0 | $1M | $95M | $-180.0K | $0 | $58.0K | $207.0K | $2M | $1M | |
| Net Change in Cash | $-7M | $-7M | $6M | $-627.0K | $-4M | $9M | $-2M | $-4M | $-84M | $79M | $9M | $-13M | $5M | $-19M | $-21M | $27M | |
| Free Cash Flow | · | $-31M | · | · | · | $-35M | · | · | · | $-33M | · | · | · | $-32M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1495.4% | -2540.4% | · | -1995.1% | -1938.5% | -2534.1% | · | -1703.9% | -665.7% | -2652.9% | · | -2637.8% | -6705.8% | -48.5% | · | -576.7% | |
| Net Margin | -1448.6% | -2402.8% | · | -1852.4% | -1786.6% | -2309.4% | · | -1551.0% | -567.4% | -2493.7% | · | -2323.6% | -5654.3% | -32.0% | · | -557.8% | |
| EBITDA Margin | -1495.4% | -2315.8% | · | -1995.1% | -1938.5% | -2329.5% | · | -1703.9% | -665.7% | -2402.4% | · | -2637.8% | -6705.8% | -41.4% | · | -576.7% | |
| ROA | -9.6% | -9.1% | · | -7.7% | -7.6% | -7.8% | · | -9.2% | -6.9% | -8.0% | · | -7.0% | -7.6% | -2.5% | · | -9.6% | |
| ROE | -14.5% | -13.3% | · | -10.8% | -10.3% | -10.5% | · | -12.5% | -9.2% | -10.6% | · | -9.8% | -10.4% | -3.4% | · | -13.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 5.8 | · | 7.9 | 8.0 | 8.8 | · | 8.3 | 9.2 | 8.7 | · | 8.8 | 8.8 | 9.0 | · | 5.2 | |
| Quick Ratio | 4.7 | 5.7 | · | 7.7 | 7.8 | 8.6 | · | 8.0 | 8.8 | 2.7 | · | 0.8 | 1.1 | 1.1 | · | 0.9 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 2.0 | 0.8 | · | 0.7 | 1.6 | 1.0 | · | 1.1 | 3.5 | 0.3 | · | 0.3 | 0.1 | 4.3 | · | 1.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.31 | $1.55 | · | $2.03 | $2.28 | $2.52 | · | $3.18 | $3.49 | $3.74 | · | $4.09 | $4.44 | $4.86 | · | $5.33 | |
| Revenue / Share | $0.02 | $0.01 | · | $0.01 | $0.02 | $0.01 | · | $0.03 | $0.06 | $0.02 | · | $0.02 | $0.01 | $0.60 | · | $0.15 | |
| Cash Flow / Share | $-0.19 | $-0.26 | · | · | · | $-0.29 | · | · | · | $-0.33 | · | · | · | $-0.29 | · | · | |
| Cash / Share | $0.28 | $0.34 | · | $0.35 | $0.36 | $0.39 | · | $0.33 | $0.32 | $1.07 | · | $0.34 | $0.47 | $0.43 | · | $0.85 | |
| EPS (TTM) | $-1.05 | $-1.09 | · | $-1.32 | $-1.45 | $-1.49 | · | $-1.65 | $-1.71 | $-1.92 | · | $-1.77 | $-2.17 | $-2.42 | · | $-3.05 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $6M | · | $7M | $8M | $13M | · | $13M | $12M | $6M | · | $106M | $119M | $137M | · | $69M | |
| Net Income TTM | $-126M | $-130M | · | $-156M | $-172M | $-176M | · | $-178M | $-176M | $-190M | · | $-173M | $-212M | $-235M | · | $-294M | |
| Market Cap | $315M | $140M | · | $145M | $128M | $91M | · | $399M | $373M | $835M | · | $209M | $469M | $560M | · | $2.18B | |
| P/E | -2.6 | -1.1 | · | -1.0 | -0.8 | -0.5 | · | -2.1 | -1.9 | -3.8 | · | -1.2 | -2.2 | -2.4 | · | -7.3 | |
| P/S | 48.5 | 22.1 | · | 20.4 | 15.2 | 6.8 | · | 29.6 | 30.3 | 128.9 | · | 2.0 | 3.9 | 4.1 | · | 31.5 | |
| P/B | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Tangible Book | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Cash Flow | -13.5 | -4.5 | · | · | · | -2.7 | · | · | · | -25.0 | · | · | · | -19.4 | · | · | |
| Earnings Yield | -38.9% | -90.8% | · | -104.8% | -129.5% | -188.6% | · | -47.1% | -52.1% | -26.2% | · | -83.5% | -45.6% | -42.5% | · | -13.6% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $7M | $14M | $64M | $96M | $56M |
| Operating Margin % | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% |
| Net Income | $-136M | $-186M | $-161M | $-282M | $-212M |
| Diluted EPS | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 |
| Quick Ratio | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-112M | $-124M | $-138M | $-284M | $-214M |
Institutional owners (13F) 160 filers · $191.7M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
160
Value held
$191.7M
New positions
33
Exited positions
30
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 33 (+2 vs prior Q) | 30 (+16 vs prior Q) | 60 (+5 vs prior Q) | 36 (+2 vs prior Q) | -1.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Redmile Group, LLC | $34,756,954 | 12,872,946 | 18.13% | Shares |
| BlackRock, Inc. | $19,707,016 | 7,298,895 | 10.28% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12,273,911 | 4,545,893 | 6.40% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,002,947 | 4,445,536 | 6.26% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $10,360,518 | 3,837,229 | 5.41% | Shares |
| TWO SIGMA INVESTMENTS, LP | $9,692,630 | 3,589,863 | 5.06% | Shares |
| JOHNSON & JOHNSON | $9,123,473 | 3,379,064 | 4.76% | Shares |
| VANGUARD GROUP INC | $8,818,834 | 8,971,347 | 4.60% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $8,054,824 | 2,983,268 | 4.20% | Shares |
| MILLENNIUM MANAGEMENT LLC | $6,571,741 | 2,433,978 | 3.43% | Shares |
| GOLDMAN SACHS GROUP INC | $5,532,805 | 2,049,187 | 2.89% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $3,571,058 | 1,322,013 | 1.86% | Shares |
| Assenagon Asset Management S.A. | $3,108,883 | 1,311,765 | 1.62% | Shares |
| JANE STREET GROUP, LLC | $2,772,919 | 1,027,007 | 1.45% | Shares |
| CITADEL ADVISORS LLC | $2,681,931 | 993,308 | 1.40% | Shares |
| Bruce & Co., Inc. | $2,670,808 | 989,188 | 1.39% | Shares |
| MORGAN STANLEY | $1,875,366 | 694,580 | 0.98% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,729,156 | 640,428 | 0.90% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,649,562 | 610,949 | 0.86% | Shares |
| TWO SIGMA ADVISERS, LP | $1,622,960 | 1,651,700 | 0.85% | Shares |
| UBS Group AG | $1,593,481 | 590,178 | 0.83% | Shares |
| Qube Research & Technologies Ltd | $1,561,005 | 578,150 | 0.81% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $1,552,487 | 574,995 | 0.81% | Shares |
| STATE STREET CORP | $1,509,106 | 558,928 | 0.79% | Shares |
| DAFNA Capital Management LLC | $1,417,500 | 525,000 | 0.74% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,379,835 | 511,050 | 0.72% | Shares |
| MARSHALL WACE, LLP | $1,329,551 | 492,426 | 0.69% | Shares |
| IEQ CAPITAL, LLC | $1,316,866 | 487,728 | 0.69% | Shares |
| Point72 Asset Management, L.P. | $1,194,016 | 442,228 | 0.62% | Shares |
| Privium Fund Management B.V. | $1,118,640 | 414,311 | 0.58% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $949,091 | 352,226 | 0.50% | Shares |
| Susquehanna Portfolio Strategies, LLC | $912,757 | 338,058 | 0.48% | Shares |
| Cerity Partners LLC | $854,028 | 341,732 | 0.45% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $733,412 | 271,634 | 0.38% | Shares |
| Invesco Ltd. | $718,151 | 265,982 | 0.37% | Shares |
| Headlands Technologies LLC | $679,865 | 251,802 | 0.35% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $663,697 | 245,814 | 0.35% | Shares |
| NORTHERN TRUST CORP | $655,212 | 242,671 | 0.34% | Shares |
| HSBC HOLDINGS PLC | $635,511 | 240,724 | 0.33% | Shares |
| LPL Financial LLC | $550,114 | 203,746 | 0.29% | Shares |
| Mariner, LLC | $518,762 | 192,215 | 0.27% | Shares |
| BARCLAYS PLC | $507,571 | 187,989 | 0.26% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $499,500 | 185,000 | 0.26% | Shares |
| XTX Topco Ltd | $488,230 | 180,826 | 0.25% | Shares |
| Aster Capital Management (DIFC) Ltd | $476,820 | 176,600 | 0.25% | Shares |
| Man Group plc | $475,489 | 176,107 | 0.25% | Shares |
| Woodline Partners LP | $431,055 | 159,650 | 0.22% | Shares |
| BANK OF AMERICA CORP /DE/ | $415,006 | 153,706 | 0.22% | Shares |
| Squarepoint Ops LLC | $414,785 | 153,624 | 0.22% | Shares |
| Arete Wealth Advisors, LLC | $405,000 | 150,000 | 0.21% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, RedCo II Offshore SPV LLC, RedCo II Master Fund, L.P. ×11 filings | April 22, 2026 | 14.90% | Amendment | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Amir Nashat (“Nashat”) ×2 filings | Dec. 21, 2018 | · | Initial filing | · | SEC |
| Dec. 5, 2016 | · | Initial filing | · | SEC | |
| ARCH Venture Fund VI, L.P., ARCH Venture Partners VI, L.P., ARCH Venture Partners VI, LLC, Clinton Bybee, Keith Crandell, Robert Nelsen ×3 filings | Aug. 15, 2016 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 30 insiders · 13 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Scott J Wolchko | President and CEO | Feb. 1, 2024 A | 371,248 | 0 | 0 | $0 |
| Christian Weyer | President and Chief Executive Officer | April 13, 2015 M | 30,429 | 0 | 0 | $0 |
| Kamal Adawi | Chief Financial Officer | Jan. 15, 2026 A | 100,000 | 0 | 0 | $0 |
| Edward J Dulac III | Chief Financial Officer | March 4, 2024 S | 101,479 | 0 | 0 | $0 |
| Jerome Charles Bressi | Chief Regulatory and Quality Officer | Jan. 15, 2025 A | 335,203 | 0 | 0 | $0 |
| Brian T. Powl | Chief Commercial Officer | July 5, 2023 S | 41,146 | 0 | 0 | $0 |
| Yu-Waye Chu | Chief Medical Officer | April 18, 2023 S | 140,676 | 0 | 0 | $0 |
| Mark Plavsic | Chief Technical Officer | Jan. 10, 2023 S | 123,705 | 0 | 0 | $0 |
| Daniel D Shoemaker | Chief Scientific Officer | March 8, 2021 S | 73,020 | 0 | 0 | $0 |
| Stewart Abbot | Chief Development Officer | May 15, 2018 M | 64,917 | 0 | 0 | $0 |
| Chris Storgard | Chief Medical Officer | Jan. 16, 2018 A | 37,593 | 0 | 0 | $0 |
| Peter D Flynn | Senior Vice President, Early Program Development | Jan. 5, 2015 A | 6,505 | 0 | 0 | $0 |
| Pratik S Multani | Chief Medical Officer | Jan. 5, 2015 A | 3,024 | 0 | 0 | $0 |
| Yuan Xu | Director | June 12, 2026 A | 8,669 | 0 | 0 | $0 |
| Karin Jooss | Director | June 12, 2026 A | 9,848 | 0 | 0 | $0 |
| Laura Hamill | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Michael Stewart Lee | Director | June 12, 2026 A | 11,331 | 0 | 0 | $0 |
| Shefali Agarwal | Director | June 12, 2026 A | 10,490 | 0 | 0 | $0 |
| Matt Abernethy | Director | June 12, 2026 A | · | 0 | 0 | $0 |
| Robert S Epstein | Director | June 12, 2026 A | 36,331 | 0 | 0 | $0 |
| William H Rastetter | Director | June 12, 2026 A | 36,331 | 0 | 0 | $0 |
| Neelufar Mozaffarian | Director | May 29, 2025 A | · | 0 | 0 | $0 |
| John Mendlein | Director | May 29, 2025 A | 311,231 | 0 | 0 | $0 |
| Timothy Coughlin | Director | June 7, 2024 A | 9,892 | 0 | 0 | $0 |
| Robert Hershberg | Director | June 6, 2023 A | 10,659 | 0 | 0 | $0 |
| Amir Nashat | Director | Aug. 1, 2019 S | 11,034 | 0 | 0 | $0 |
| Mark J Enyedy | Director | May 11, 2016 A | · | 0 | 0 | $0 |
| Robert Nelsen | Director | Oct. 4, 2013 C | 2,473,188 | 0 | 0 | $0 |
| Bahram Valamehr | · | Aug. 4, 2026 S | 591,815 | 0 | 3 | $-168,081 |
| Cindy Tahl | · | Aug. 4, 2026 S | 589,355 | 0 | 3 | $-154,781 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.50% | 48,339 SH | Oct. 23, 2026 | Daily |
| IWC · iShares Trust | 0.06% | 387,392 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 242,271 SH | Oct. 23, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 15,790 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 6,246 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,149,276 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,194,411 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.00% | 272,591 SH | Aug. 19, 2026 | Daily |
FATE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$7.00
+231.8%
5 27.8%
Strong Buy
6 33.3%
Buy
7 38.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-10-22Mean target $5.74 +172.2%
← Below all targets
Current price $2.11
Low$2.20
Mean$5.74
High$8.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| RCKT | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026